Surface glycan modification of cellular nanosponges to promote SARS-CoV-2 inhibition

Summary

This study asks whether host-mimicking cellular nanosponges can be strengthened by adding a second class of viral binding partner to their surface. SARS-CoV-2 entry depends on spike-protein engagement with ACE2 and can also involve glycosaminoglycans such as heparin. The researchers produced nanosponges from membranes of host cells engineered to display azido groups, then chemically attached heparin at controlled surface densities. This retained the natural receptor-decoy concept while adding a glycan-based interaction. Nanosponges carrying more heparin bound greater amounts of viral spike protein and inhibited SARS-CoV-2 infectivity more effectively than lower-density counterparts. The central result is a direct relationship between surface heparin density, spike-binding capacity, and antiviral inhibition in the tested system. It demonstrates that the biological interface of a membrane-coated decoy can be deliberately edited rather than accepted as fixed. The significance is a relatively simple surface-glycan engineering method for increasing the potency of host-cell mimics, with a proposed extension to other viruses whose entry depends on glycans. The abstract does not identify the infection model in detail or report in vivo protection, pharmacology, safety, or activity against specific viral variants.